1 Min Read
LONDON, Jan 3 (Reuters) - Chroma Therapeutics Ltd: * Chroma Therapeutics extends collaboration with gsk, and advancesnovel
targeted agent towards clinical development; receives milestonepayment
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.